The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial

Peer Review reports

Original Submission
11 May 2020	Submitted	Original manuscript
11 May 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
14 May 2020	Editorially accepted
8 Jun 2020	Article published	10.1186/s13063-020-04421-z

Back to article page